Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 12/05/2026

    The Silent Killer: Early Detection and Targeted Treatment of High Blood Pressure

    High blood pressure is one of the most common causes of heart attacks, strokes, kidney damage, and vascular diseases. Many people affected experience no symptoms for a long time. This is precisely why it is important to check your blood pressure regularly. To mark World Hypertension Day on May 17, the Medical Center – University of Freiburg is providing information on warning signs, diagnosis, and treatment options.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/silent-killer-early-detection-and-targeted-treatment-high-blood-pressure
  • Press release - 11/05/2026

    Radar warns of a risk of falling at the hospital

    The Medical Center – University of Freiburg has implemented a new system that helps nurses identify risky situations early on and provide more targeted assistance / Motion detection is performed using radar

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/radar-warns-risk-falling-hospital
  • Press release - 13/05/2026

    NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies

    NVision announced a $55 million Series B led by Abbott and unveiled PIQC, a new quantum computing platform built on its molecular quantum technology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nvision-expands-quantum-sensing-quantum-computing-accelerate-discovery-and-validation-new-therapies-en
  • Press release - 18/05/2026

    Gene scissors show promise for treating a rare immune disorder

    Medical Center – University of Freiburg demonstrates a fundamental therapeutic approach for hereditary immune system defects in a mouse model. The safety profile of genome editing varies significantly depending on the method and cell type.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-scissors-show-promise-treating-rare-immune-disorder
  • Press release - 15/05/2026

    Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period

    The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
  • Funding

    Funke Quantum-Driven Intelligence

    Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026
    https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantum-driven-intelligence
  • Funding

    Funke QuantumSense Exploration

    Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026
    https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantumsense-exploration
  • Event - 17/09/2026 - 18/09/2026

    Translational Protein Biomarker Workshop

    Reutlingen, Informationsveranstaltung
    https://www.gesundheitsindustrie-bw.de/en/event/translational-protein-biomarker-workshop
  • Press release - 15/05/2026

    Neuroendocrine Tumors: Freiburg Becomes a European Center of Excellence

    The Medical Center – University of Freiburg has been certified for the first time as a “Center of Excellence” by the European Neuroendocrine Tumor Society (ENETS). The professional association recognizes specialized centers that treat rare tumor diseases in accordance with established quality standards. Neuroendocrine tumors are rare cancers that can arise from hormone-producing cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/neuroendocrine-tumors-freiburg-becomes-european-center-excellence
  • Funding

    Continuous Hormone Monitoring

    Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 26/06/2026
    https://www.gesundheitsindustrie-bw.de/en/database/funding/continuous-hormone-monitoring
  • Press release - 18/05/2026

    Unlocking the Lung’s Ability to Heal: NK Cell Immunotherapy offers New Hope for Fibrosis

    Research jointly led by scientists at the Heidelberg site of the German Center for Lung Research and investigators in Boston at Massachusetts General Hospital and Harvard Medical School identifies a new immunotherapy-based approach for lung fibrosis: reactivating natural killer cell (NK cells) to eliminate senescent fibroblasts, reverse scarring and restore the lung’s ability to heal.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/unlocking-lungs-ability-heal-nk-cell-immunotherapy-offers-new-hope-fibrosis

Page 39 / 39

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search